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Many steps of peripheral glia development appear to be regulated by neuregulin1 (NRG1) signaling but the exact roles of the
different NRG1 isoforms in these processes remain to be determined. While glial growth factor 2 (GGF2), a NRG1 type II
isoform, is able to induce a satellite glial fate in neural crest stem cells, targeted mutations in mice have revealed a
prominent role of NRG1 type III isoforms in supporting survival of Schwann cells at early developmental stages. Here, we
investigated the role of NRG1 isoforms in the differentiation of Schwann cells from neural crest-derived progenitor cells. In
multipotent cells isolated from dorsal root ganglia, soluble NRG1 isoforms do not promote Schwann cell features, whereas
signaling by membrane-associated NRG1 type III induces the expression of the Schwann cell markers Oct-6/SCIP and S100
in neighboring cells, independent of survival. Thus, axon-bound NRG1 might actively promote both Schwann cell survival
and differentiation. © 2002 Elsevier Science (USA)
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The neuregulins (NRGs) are a family of structurally
related glycoproteins with many functions in the develop-
ing nervous system (reviewed in Adlkofer and Lai, 2000;
Lemke, 2001). NRG1, the best characterized of the four
known NRG genes, encodes various isoforms that differ
substantially in overall structure. NRG1 isoforms were
originally named on the basis of distinct biological assays
used for their identification and have later been classified in
three major groups (Burden and Yarden, 1997): NRG1 type I
(neu differentiation factor, NDF; heregulin; acetylcholine
receptor inducing activity, ARIA) is prominently expressed
early in development of nonneural tissue (Falls et al., 1993;
Holmes et al., 1992; Wen et al., 1992); NRG1 type II (glial
growth factor, GGF) is expressed mainly in the nervous
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sory and motor neuron-derived factor, SMDF; cystein-rich
domain (CRD)-NRG1] is the major isoform expressed by
peripheral sensory and motor neurons, and is also produced
in the brain (Bermingham-McDonogh et al., 1997; Ho et al.,
1995; Yang et al., 1998). The common feature of these
NRG1 isoforms is an EGF-like domain that is required for
receptor binding and on its own is sufficient to elicit ErbB
receptor-mediated activation of downstream signaling path-
ways (Holmes et al., 1992). While NRG1 types I and II share
an immunoglobulin domain as part of their extracellular
portion, the principal form of NRG1 type III contains a
unique N-terminally located hydrophobic domain that me-
diates membrane insertion with the EGF homology domain
exposed to the extracellular compartment (Schroering and
Carey, 1998; Wang et al., 2001).
Roles for NRG1 signaling in neural development have
been analyzed in mice carrying selective mutations of
NRG1 ectodomains. Mice homozygous for NRG1 lacking
the EGF-like domain common to all isoforms display car-
diac malformation and die around embryonic day 10.5
(E10.5) (Meyer and Birchmeier, 1995). Besides considerable
loss of neuronal cell populations, they exhibit severely11 90. E-mail: sommer@cell.biol.ethz.ch.
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FIG. 1. A 24-h survival assay with Schwann cell precursors. Sciatic nerves isolated from rat E14.5 embryos were dissociated and the cells
were fixed at 3 or 24 h after culturing in the presence of soluble NRG1 type II (NRG1-II) or type III (NRG1-III). Immunostaining for p75 using
a fluorescent Cy3-coupled secondary antibody revealed that the cultures mainly consisted of Schwann cell precursor cells. Shown are
representative fields of Schwann cell precursor cultures 3 (A, B) and 24 h (C–H) after plating. Phase-contrast (B, D, F, and H). Magnification,
20. (I) Cells that were immunoreactive to p75 antibody and that showed an intact nucleus (defined by means of DAPI staining) were
considered for counting in order to determine relative survival rate. Total numbers of cells per coverslip of 24-h cultures were compared
with the total number of p75-positive cells plated (3-h cultures, approx. 200 cells/coverslip). For each condition, three independent
experiments were performed in triplicate. Relative survival rate of Schwann cell precursors is given in percentage  SD.
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reduced numbers of presumptive glial cells in cranial gan-
glia and of Schwann cell precursors along peripheral nerves.
Homozygous deletion of the exon encoding the immuno-
globulin domain results in the specific loss of NRG1 type I
and type II isoforms without affecting expression of NRG1
type III. Mice carrying this mutation also die around E10.5
with similar heart defects to those described above; how-
ever, early development of the peripheral glial lineage is not
affected (Kramer et al., 1996; Meyer et al., 1997). Further-
more, the nerves of NRG1 type III-deficient mice are
initially populated by Schwann cell precursors, but are
devoid of Schwann cells later in development (Wolpowitz et
al., 2000). The culmination of these genetic data indicate
that NRG1 type III is required for Schwann cell develop-
ment. However, it is unclear from these findings whether
NRG1 type III is solely required to support survival of
developing Schwann cells along the axons or whether
NRG1 type III can also act as a differentiation cue that
promotes maturation of Schwann cell precursors into early
Schwann cells.
In vitro studies might allow discrimination between the
specific roles of NRG1 in migration, survival, and differentia-
tion of neural crest derivatives. With respect to early Schwann
cell development, variants of NRG1 type I were shown to
promote survival and maturation of cultured Schwann cell
precursors isolated from peripheral nerves (Dong et al., 1995;
Dong et al., 1999; Brennan et al., 2000). A role for NRG1 in
glial differentiation has also been shown in cultures of multi-
potent neural crest stem cells and neural crest derivatives that
are instructed by NRG1 type II to choose a glial fate (Hagedorn
et al., 1999; Shah et al., 1994). However, NRG1 type II-treated
cells differentiate into satellite glia expressing the transcrip-
tion factor Erm and not into Schwann cells of the peripheral
nerve that express the transcription factor Oct-6 (Hagedorn et
al., 2000). Based on the expression and genetic data, Schwann
cell development in vivo might rather be regulated by NRG1
type III. Therefore, we here elucidated the potential functions
of NRG1 type III in the Schwann cell lineage, using culture
systems in which survival and differentiation can be investi-
gated separately and independently of migration.
MATERIALS AND METHODS
Cell Cultures
Time-mated OFA rats were obtained from RCC Ltd. (Fu¨llinsdorf,
Switzerland).
Schwann cell precursor cultures. Cultures of rat Schwann cell
precursors were prepared essentially as described by Lobsiger et al.
(2000). Briefly, sciatic nerves were dissected from rat E14.5 em-
bryos and dissociated by incubation for 60 min at 37°C in 0.2%
collagenase type IV (Worthington Biochemical Corp.), 0.12% hyal-
uronidase type IV-S (Sigma), and 0.03% trypsin inhibitor (Sigma).
Cells were plated onto poly-L-lysine (Sigma)-, laminin (Sigma)-
coated 15-mm glass coverslips (Arnold Bott AG) and cultured in
defined medium with or without additional growth factors that
were given to the medium 3 h after plating. Defined culture
medium was used as previously described by Dong et al. (1995). For
the Schwann cell precursor survival assay, cells were plated at low
density (approx. 200 cells/coverslip) and cultured in defined me-
dium supplemented with soluble forms of either recombinant
human NRG1 type III (also referred to as SMDF; R&D Systems) or
recombinant human NRG1 type II (also referred to as rhGGF2; a
gift from M. A. Marchionni, Cambridge NeuroScience), for 24 h
prior to fixation with 3.7% paraformaldehyde in PBS. Long-term
survival and differentiation were tested by plating the cells at high
density and by extending the survival assay described above to 5
days. All assays were performed in triplicate.
DRG cell cultures. Cultures of rat DRG cells were prepared
exactly as described by Hagedorn et al. (2000). DRG were dissected
from rat E15 embryos and dissociated by incubation in 0.25%
trypsin (GIBCO/BRL), 0.03% collagenase type I (Worthington Bio-
chemical) for 20 min at 37°C. Cells were plated at approximately
10.000–20.000 cells per 35-mm culture dish (Corning) coated with
poly-D-lysine (Roche Diagnostics) and fibronectin (Roche Diagnos-
tics). DRG cultures were maintained in standard culture medium
(Hagedorn et al., 1999; Stemple and Anderson, 1992). Four hours
after plating, the medium of some culture dishes was supple-
mented with either soluble NRG1 type III (SMDF; R&D Systems),
soluble NRG1 type II (rhGGF2; Cambridge NeuroScience), or
forskolin (Sigma). Cells were cultured for 4 days prior to fixation
with 3.7% formaldehyde in PBS.
Construction of Retroviral Vectors
Vector construction was performed by using standard molecular
cloning techniques.
mycNRG1-III retrovirus. A NRG1 type III cDNA (SMDF; a gift
from D. J. Carey, Penn State College of Medicine) was cloned
in-frame into a retroviral vector called pBabeMT.APPuro. The
vector has a myc-epitope tag upstream of the cloning site and is
described in detail by Lo et al. (1997). The plasmid contains an
internal ribosomal entry site (IRES)-human placental alkaline phos-
phatase cassette downstream of the cloning site.
NRG1-III retrovirus. The NRG1 type III cDNA described
above was cloned in-frame into a retroviral vector called pBabe.AP-
Puro. The vector corresponds to pBabeMT.APPuro lacking the
myc-epitope tag.
FIG. 2. Long-term survival of Schwann cell precursors in the presence of NRG1 type II and III, and differentiation into early Schwann cells.
Dissociated rat E14.5 nerves were plated and cultured over a period of 5 days in medium supplemented with soluble forms of NRG1 type
II or type III (1 nM each). Fixed cells were immunolabeled by using anti-p75 and anti-S100 antibody visualized by FITC-conjugated and
Cy-3-conjugated secondary antibody, respectively (A, C, E, and G). Differentiation of Schwann cell precursor cells (A, B, 3-h cultures) into
early Schwann cells (E–H, 5-day cultures) is marked by the upregulation of S100 expression. In the absence of any survival cue, virtually
all cells died within 5 days (C, D). (I) Percentage of cells (SD) that were found to be double-positive for the expression of p75 and S100 was
determined in four independent experiments. Between 100 and 150 p75-positive cells were scored per experiment. Note that many of the
p75-positive cells do not express S100 (arrow). Phase-contrast (B, D, F, and H). Magnification, 20.
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Control retrovirus. A GFP cDNA (pGreen Lantern, GIBCO/
Life Technologies) was cloned into a reengineered form of the
retroviral vector pBabe.APPuro. The vector was modified by intro-
ducing GFP cDNA downstream of a tag that consisted of a nuclear
localization signal (NLS) fused in-frame to the myc-epitope.
Viral supernatants for infection of DRG cell cultures were
produced by transient transfection in Phoenix cells as described
(http://www.uib.no/mbi/nolan/nl-phoenix.html).
Retroviral Infection of DRG Cells
Approximately 250,000 freshly isolated rat E15 DRG cells were
plated on a fibronectin (Roche Diagnostics) substrate in a 35-mm
dish (Corning). Cell cultures were maintained in standard culture
medium (SM) for 3.5 h and then flushed four to five times with
ice-cold PBS in order to remove most of the sensory neurons
present in the culture. Cells were removed from culture dishes
with 0.25% trypsin (GIBCO/BRL) for 2 min and replated at a
density of 10.000–20.000 cells per 35-mm culture dish coated with
poly-D-lysine (Roche Diagnostics) and fibronectin (Roche Diagnos-
tics). NRG1-III- and mycNRG1-III-expressing as well as control
retroviral supernatants were diluted 1:4 with SM and added to the
cells. After a 3-h incubation at 37°C, the viral solution was
removed and the culture was allowed to recover in fresh SM for 1 h.
The infection procedure was repeated once. Following infection,
incubation continued in fresh SM. After 4 days of culture, cells
were fixed in 3.7% formaldehyde in PBS and stained for the desired
epitopes.
Immunocytochemistry
Cells were fixed in PBS containing 3.7% formaldehyde for 10
min at RT. Labeling of the cell surface antigen p75/LNGFR was
performed in 10% goat serum, 0.1% BSA in PBS using a polyclonal
rabbit anti-mouse p75 antibody (1:300 dilution; Chemicon) visual-
ized by either FITC-conjugated donkey anti-rabbit IgG (1:200
dilution; Jackson ImmunoResearch Laboratories) or Cy3-coupled
goat anti-rabbit IgG (1:500 dilution; Jackson ImmunoResearch
Laboratories). To label intracellular antigens, cells were permeabil-
ized for 20 min at RT by using 10% goat serum, 0.3% Triton X-100,
0.1% BSA in PBS. To reveal expression of S100, labeling (rabbit
anti-cow S100; DAKO; 1:400 dilution) was performed for 1 h at RT
and visualized by either Cy3 or FITC fluorescence. Rabbit anti-Oct-
6/SCIP antibody (Zwart et al., 1996) (a gift from D. Meijer, Erasmus
University, Rotterdam, The Netherlands) was used at a 1:200
dilution and visualized with FITC fluorescence. To visualize myc-
epitope tagged proteins, mouse monoclonal anti-human c-Myc
antibody (9E10; 1:3 dilution; Developmental Studies Hybridoma
Bank) was applied for 1 h at RT, followed by staining with
Cy3-conjugated (1:300 dilution; Jackson ImmunoResearch Labora-
tories) goat anti-mouse IgG. AP labeling was performed with
monoclonal anti-human alkaline phosphatase antibody (placental,
clone 8B6; 1:300 dilution; Sigma) followed by incubation with
Cy3-coupled IgG. Nuclei of the cells were visualized with DAPI (1
g/ml), a chromosome-specific fluorescent dye. Stained fixed cul-
tures were embedded in AF1/Citifluor (Chemical Laboratory).
RESULTS
NRG1 Type III Rescues Schwann Cell Precursors
in a 24-h Survival Assay
In order to address the cellular role of the NRG1 type III
isoform in early stages of Schwann cell development, we
exposed Schwann cell precursor cells to a soluble form of
NRG1 type III. Schwann cell precursors were freshly iso-
lated from embryonic rat sciatic nerves at E14.5 and cul-
tured in defined medium, as described previously (Dong et
al., 1995; Jessen et al., 1994; Lobsiger et al., 2000). In a first
experiment, a standard 24-h survival assay was performed
(Jessen et al., 1994). Approximately 200 cells were plated
per 15-mm coverslip, and the medium was supplemented
with different concentrations of NRG1 type III. In parallel,
cells on sister coverslips were exposed to a soluble NRG1
type II isoform (GGF2) (Marchionni et al., 1993) that has
been shown to have a gliogenic effect on neural crest cells
(Shah et al., 1994). The survival of Schwann cell precursors
was assessed by comparing the number of viable p75-
positive cells after 24 h to the number of p75-positive cells
plated (Jessen et al., 1994) (Fig. 1). Virtually no cells express-
ing the precursor marker p75 were found 24 h after plating
when cultured in defined medium alone (Figs. 1C and 1D).
In contrast, when the medium was supplemented with
NRG1 type II or type III, a significant number of p75-
positive cells survived (Figs. 1E–1H). Survival in the pres-
ence of 1 nM NRG1 type II was close to 100%, while in the
presence of 1 nM or more NRG1 type III, maximal survival
was 60% (Fig. 1I). Thus, similar to NRG1 type I isoforms
(Dong et al., 1995), both type II and type III isoforms of
NRG1 prevented death of Schwann cell precursors, albeit at
different efficiencies.
Assessing Maturation of Schwann Cell Precursors
in the Presence of Soluble NRG1 Type III
Previously, it has been shown that long-term survival of
Schwann cell precursors promoted by NRG1 type I isoforms
was accompanied by differentiation of the precursors to
early Schwann cells (Dong et al., 1995, 1999). Therefore, we
addressed whether other NRG1 isoforms also support long-
term survival and maturation of Schwann cell precursors.
TABLE 1
Association of Schwann Cells with NRG1 Type III-Expressing Cells
Control (%) n NRG1-III (%) n P value
Exp. 1 0 20 55.0 20 0.0004
Exp. 2 0 39 61.5 39 1.78
Note. Quantification of NRG1 type III-induced upregulation of
Schwann cell traits in multiple neighboring cells. Association of
Schwann cells with infected cells was scored when at least four
Oct-6-positive Schwann cells were found in close association with
an infected cell (identified by AP expression). Relative numbers are
given in percentage of infected cells associated with Schwann cells.
Two independent experiments (Exp. 1, Exp. 2) were performed. A 2
test was used to calculate P values.
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FIG. 3. Soluble NRG1 type II and type III do not induce expression of the Schwann cell-specific marker Oct-6 in neural crest-derived
multipotent progenitor cells. Dorsal root ganglia isolated from rat E15 embryos were dissociated and the cells were plated at high density.
Cultures were challenged with soluble forms of NRG1 type II or type III (1 nM each) over a period of 4 days. Fixed cells were labeled
immunocytochemically for Oct-6. Staining was visualized with FITC-coupled secondary antibody. Schwann cell differentiation, as
monitored by the expression of Oct-6, is induced by supplying the culture medium with forskolin (C, D). Addition of NRG1 type II or type
III to the medium had no effect on Oct-6 expression (E, F) when compared with untreated sister plates (A, B). Phase-contrast (B, D, F, and
H). Magnification, 20.
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Precursor cells were plated at high density in defined
medium and treated with soluble forms of either NRG1
type II or type III over a period of 5 days. Differentiation into
early Schwann cells was monitored by the upregulation of
S100. In the presence of NRG1 type II, little cell death was
observed as monitored by DAPI-staining of fragmented
nuclei (data not shown). Moreover, 61  9% of the NRG1
type II-treated p75-positive cells displayed increased S100
immunoreactivity when compared with precursors on sis-
ter plates that were fixed 3 h after plating (Figs. 2A–2F and
2I). In medium supplied with NRG1 type III, many cells
showed fragmented nuclei (data not shown), but a substan-
tial proportion of the cells survived in these conditions
(Figs. 2G and 2H). While virtually all of the surviving cells
were p75-immunoreactive, 54  14% of these cells also
expressed S100 (Figs. 2G and 2I). Thus, many NRG1 type II-
and type III-treated cells survived without differentiation,
suggesting that the transition from Schwann cell precursors
to early Schwann cells is not a cell-autonomous process
that unfolds in cells prevented from undergoing apoptotic
death (Jessen and Mirsky, 1998; Brennan et al., 2000).
Rather, it is likely that both survival and differentiation
have to be actively promoted by extracellular cues.
Membrane-Bound but Not Soluble NRG1 Type III
Promotes Schwann Cell Differentiation from
DRG-Derived Multipotent Progenitor Cells
To identify signals that promote Schwann cell differen-
tiation independent of survival, we employed a culture
system of neural crest-derived cells in which cell death is
minimal. Nonneuronal neural crest-derived cells isolated
from early dorsal root ganglia (DRG) are multipotent, giving
rise to neurons, satellite glia, and Schwann cells, as well as
to nonneural cells, depending on the environmental condi-
tions (Hagedorn et al., 1999, 2000). Moreover, although the
survival of at least a subpopulation of these cells is sup-
ported by NRG1 signaling (Paratore et al., 2001), we have
established conditions in which more than 95% of progeni-
tor cells isolated from embryonic rat DRG survive in the
absence of exogenously added NRG1 (Hagedorn et al.,
1999). In agreement with previous studies (Hagedorn et al.,
2000; Zorick and Lemke, 1996), such progenitor cells de-
rived from rat E15 DRG only occasionally adopted Schwann
cell features while most of the cells displayed no or only
weak expression of Schwann cell markers when cultured in
standard medium (Figs. 3A and 3B). However, these cells
were competent to generate Schwann cells upon treatment
for 4 days with forskolin, which elevates intracellular
cAMP. Schwann cell differentiation was monitored by
increased expression of the transcription factor Oct-6 (also
called SCIP or Tst-1; He et al., 1989; Meijer et al., 1990;
Monuki et al., 1989) (Figs. 3C and 3D) and S100 (not
shown). The NRG1 type II isoform GGF2 has been shown
to regulate satellite gliogenesis in DRG-derived progenitor
cells but did not induce expression of the Schwann cell
marker Oct-6 (Figs. 3E and 3F; Hagedorn et al., 2000).
Likewise, addition of soluble NRG1 type III (1 nM) had no
effect on Oct-6 levels and did not induce S100 expression
(Figs. 3G and 3H; and data not shown). Moreover, Schwann
cell differentiation of DRG-derived progenitor cells was not
observed even when using concentrations of NRG1 type III
(10 nM) 10-fold above saturation for survival and differen-
tiation of sciatic nerve-derived Schwann cell precursors
(data not shown).
Hydrophobic amino acids in the N-terminal domain of
NRG1 type III confer membrane association (Schroering
and Carey, 1998; Wang et al., 2001). Thus, the activity of
NRG1 type III might depend on whether the factor is
presented to cells as soluble or membrane-bound form. To
address this issue, we sought to overexpress the factor in
cultured cells to allow local NRG1 signaling to neighboring
cells. Retroviral expression vectors were generated encod-
ing (1) the NRG1 type III isoform carrying a human myc-
epitope tag; (2) NRG1 type III without a myc-epitope tag;
and (3) an inert protein (nuclear green fluorescence protein,
GFP) fused to a myc-epitope tag, serving as control (Fig. 4).
As a further marker of infected cells, all three vectors
encoded alkaline phosphatase (AP) driven from an IRES.
Immunostaining using an antibody to the myc-epitope tag
was consistent with cell surface localization of NRG1 type
III in infected postmigratory neural crest cells (Fig. 5), in
agreement with previous reports that biochemically dem-
onstrated membrane association of NRG1 type III upon
cellular expression (Schroering and Carey, 1998; Wang et
al., 2001).
To address the role of cell surface-associated NRG1 type
III in Schwann cell differentiation of multipotent progenitor
cells, nonneuronal cells were isolated from DRG (see Ma-
terials and Methods) and plated at high density to allow
short range cell–cell interactions. The undifferentiated
cells were infected 3 h after plating either with retroviral
vector-encoding NRG1 type III fused to a myc-epitope tag
(mycNRG1-III) or with control retroviral vector (Fig. 4).
FIG. 4. Retroviral expression constructs encoding membrane-
bound NRG1 type III. cDNAs encoding myc-tagged NRG1 type III
(mycNRG1-III) or NRG1 type III without epitope tag (NRG1-III)
were inserted into retroviral expression constructs. Control infec-
tions were performed by using a virus encoding a GFP fusion
protein with a myc-epitope tag and a nuclear localization signal
(NLS). Infected cells can be revealed by immunocytochemical
detection of the myc-epitope tag or alkaline phosphatase (AP). LTR,
long terminal repeats.
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Four days postinfection, the cells were fixed and immuno-
stained with antibodies against the myc-epitope tag and
S100. In none of the infected cultures did we observe a
general, wide-spread upregulation of Schwann cell markers
as seen upon addition of forskolin (Fig. 3). However, many
NRG1 type III-expressing cells were associated with cells
expressing high levels of S100 (Figs. 5C and 5D). Intrigu-
ingly, processes of NRG1-expressing cells were often found
in close contact to S100-positive cells (arrow in Fig. 5C). In
addition, cells in close proximity to NRG1 type III-
expressing cells also expressed Oct-6 (Figs. 5G and 5H). As
with S100-expressing cells, a striking correlation between
Oct-6 labeling and cellular association with processes of
NRG1 type III-positive cells was seen (arrow in Fig. 5G). By
contrast, control-infected cells were mostly not associated
with S100- or Oct-6-positive cells (Figs. 5A, 5B, 5E, and 5F).
Expression of Oct-6 in some cells of control cultures might
have been due to cellular association with neurites of
residual neurons possibly present in the cultures. However,
staining for neurofilament only revealed very few neurons
both in control and in mycNRG1-III-infected cultures, so
that neuronal contact could not account for induction of
Oct-6 expression in adjacent cells (data not shown). While
the presence of few Oct-6-positive cells in control cultures
might thus reflect a possible heterogeneity in the cultures,
the strong association of Oct-6-expressing cells with
mycNRG1-III-infected cells indicates that direct cell–cell
contact resulted in NRG1 type III-mediated induction of
the Schwann cell markers.
To exclude an involvement of membrane-associated
myc-epitope tag in Schwann cell differentiation, neural
crest-derived progenitor cells were infected with a retrovi-
rus encoding NRG1 type III without epitope tag (Fig. 4).
Expression from the retroviral construct was monitored by
staining for AP. Similar to epitope-tagged NRG1, the un-
tagged form was also able to induce expression of both S100
and Oct-6 in neighboring cells, confirming the specificity of
NRG type III in inducing a Schwann cell phenotype (Fig. 6).
To quantify NRG1 type III-induced upregulation of
Schwann cell markers, we counted cohorts of infected cells
that displayed Schwann cell marker expression in their
vicinity (Fig. 7). Thereby, association of Schwann cells with
infected cells was scored when at least one Oct-6- or one
S100-positive cell was found in direct contact with an
infected cell, and only cells strongly expressing S100 or
Oct-6 (as e.g., shown in Figs. 5C and 5G) were taken into
account. This conservative method represents the most
sensitive way to measure a Schwann cell-inducing activity.
Using these criteria, 30  10% of the control-infected cells
were associated with S100-positive cells. In contrast, 71 
5% of the NRG1 type III-expressing cells were found in
close proximity to S100-positive Schwann cells. Likewise,
Oct-6 staining was detectable adjacent to 71  7% of the
NRG1 type III-expressing cells, while this number
amounted to only 26  5% in the control-infected cultures.
Similar numbers were obtained when Schwann cell differ-
entiation was monitored in the vicinity of cells expressing
untagged NRG1 (data not shown). The finding that even in
control cultures some infected cells were found in proxim-
ity with a Schwann cell is likely due to random association
of infected cells with single Schwann cells occasionally
present in the culture independently of NRG1-expressing
cells. To confirm the specificity of NRG1-dependent induc-
tion of Schwann cell traits, we performed two independent
experiments in which association of Schwann cells was
only counted when at least four cells were found in close
vicinity to an infected cell (as e.g., represented in Fig. 5G).
Using these stringent criteria, 55–61.5% of cells expressing
membrane-bound NRG1 were surrounded by Oct-6-
expressing Schwann cells (Table 1). In contrast, we never
observed control-infected cells to be associated with four or
more Schwann cells (Table 1). Thus, a highly significant
relationship between cells expressing NRG1 and cells
marked by S100 or Oct-6 was established by using different
criteria of quantification (Fig. 7; and Table 1), revealing a
specific role for membrane-bound NRG1 type III in promot-
ing Schwann cell differentiation.
DISCUSSION
The loss of Schwann cell precursors in mice deficient in
components of the NRG1 signal transduction pathway
precludes the analysis of a direct involvement of NRG1 in
Schwann cell differentiation (Meyer et al., 1997; Morris et
al., 1999; Riethmacher et al., 1997; Woldeyesus et al., 1999;
Wolpowitz et al., 2000). Appropriate culture systems turn
out to be valuable tools to address this issue. Although
NRG1 promotes survival and differentiation of Schwann
cell precursors isolated from peripheral nerves (Dong et al.,
1995, 1999; Brennan et al., 2000), soluble NRG1 induces the
generation of satellite glia rather than Schwann cells in
multipotent neural crest cells (Hagedorn et al., 2000). In
this study, we demonstrate that membrane-associated
NRG1 type III, in contrast to soluble NRG1 isoforms, has
the potential to induce the Schwann cell markers Oct-6 and
S100 in cultures of multipotent neural crest-derived pro-
genitors. Since cell death is minimal in the conditions
chosen (Hagedorn et al., 1999), our data identify locally
presented NRG1 type III as an active Schwann cell differ-
entiation signal.
Role of NRG1 Isoforms in Survival of Peripheral
Progenitor Cells
In previous reports, variants of the type I isoform have
been used to demonstrate the survival-promoting activity
of NRG1 on Schwann cell precursors (Dong et al., 1995,
1999). However, the late and restricted expression of NRG1
type I in the peripheral nervous system (PNS) makes this
isoform unlikely to be involved in early Schwann cell
development in vivo (Meyer et al., 1997). Given their strong
expression in sensory and motor neurons and based on in
vivo functional analysis, NRG1 type II and, in particular,
252 Leimeroth et al.
© 2002 Elsevier Science (USA). All rights reserved.
type III might be crucial for the early development of the
Schwann cell lineage (Ho et al., 1995; Meyer et al., 1997;
Wolpowitz et al., 2000). Schwann cell precursors are absent
in mutants in which signaling by both of these NRG1 forms
is affected, whereas Schwann cell precursors are found
along peripheral nerves in mutants lacking either type II or
type III isoform (Meyer et al., 1997; Morris et al., 1999;
Riethmacher et al., 1997; Woldeyesus et al., 1999; Wolpo-
witz et al., 2000). Thus, type II and type III isoforms might
compensate each other to regulate the earliest steps in
Schwann cell precursor generation. Depletion of Schwann
cell precursors in NRG1 mutants might be due to cell death
of neural crest-derived progenitors. The survival of at least
some multipotent progenitors is supported by NRG1 sig-
naling (Paratore et al., 2001), and, as we show here, both
NRG1 type II and type III are able to promote survival of
Schwann cell precursors in vitro. In addition, a role of
NRG1 isoforms in regulating progenitor migration into
peripheral nerves is conceivable (Britsch et al., 1998; Morris
et al., 1999).
Survival at a somewhat later stage in development, dur-
ing the transition from a Schwann cell precursor to an early
Schwann cell, is likely controlled by NRG1 type III. In mice
carrying a type III-specific mutation, Schwann cell precur-
sors initially form along peripheral nerves but are then
progressively lost (Wolpowitz et al., 2000). Our results
indicate that soluble NRG1 type III is able to support
survival of Schwann cell precursors, although less effi-
ciently than other NRG1 isoforms (Dong et al., 1995, 1999;
Brennan et al., 2000). Thus, it is likely that NRG1 type III
acts in combination with factors such as FGF2, PDGF-BB,
and NT-3 to promote survival of Schwann cell precursors
(Dong et al., 1995, 1999; Lobsiger et al., 2000). Moreover,
the retention of NRG1 type III at the cell surface (Schroer-
ing and Carey, 1998; Wang et al., 2001) might increase its
anti-apoptotic activity. According to this model, neuron-
derived NRG1 signaling would support only those Schwann
cell precursors that directly contact the axon. Such a
mechanism, in concert with mitotic stimuli, would ensure
a tight control of the Schwann cell number to be produced
along the nerve.
Isoform-Specific Activities of NRG1 in Schwann
Cell Differentiation
In cultures of Schwann cell precursors isolated from
sciatic nerve, only about 54–61% of the surviving cells
displayed upregulated expression of Schwann cell differen-
tiation markers after treatment with soluble NRG1 type II
or type III. This number is lower than the differentiation
rate observed by other authors, who used various soluble
NRG1 type I forms or an isolated EGF domain of NRG1
(Dong et al., 1995, 1999; Brennan et al., 2000). The discrep-
ancy might be due to different NRG1 variants used or to
subtle differences in culture conditions. Moreover, matura-
tion of only a subpopulation of Schwann cell precursors
might reflect heterogeneity of the cells. In any case, our
data suggest that survival per se is not sufficient for full
differentiation of Schwann cell precursors. Rather, differen-
tiation might have to be actively promoted independently
of survival. This is also supported by the recent report that
endothelins act as survival factors of Schwann cell precur-
sors while delaying their differentiation (Brennan et al.,
2000). Apparently, secreted NRG1 type II and III isoforms
do not represent efficient Schwann cell differentiation fac-
tors. This is particularly evident in multipotent progenitors
isolated from early DRG. With these cells, formation of
Schwann cells was not stimulated by soluble NRG1 iso-
forms, even when added well above saturation. In contrast,
forced cellular expression of NRG1 type III specifically
induced Schwann cell traits in adjacent cells, demonstrat-
ing that local presentation of NRG1 is required to reveal its
direct involvement in Schwann cell differentiation. In
agreement with a role of membrane-bound, axon-derived
NRG1 type III in regulating Schwann cell features, axon–
Schwann cell interactions have been shown to upregulate
the expression of Oct-6 in Schwann cells (Scherer et al.,
1994). As mentioned above, soluble NRG1 type II regulates
a satellite glial fate rather than Schwann cell development
in DRG-derived multipotent progenitors (Hagedorn et al.,
2000). Intriguingly, simultaneous exposure of multipotent
progenitors to NRG1 type II and membrane-bound NRG1
type III did not block the Schwann cell promoting activity
of the type III isoform (data not shown), suggesting that
axon-mediated NRG1 signaling is dominant over signaling
by secreted NRG1.
Analysis of mutant mice revealed an important function
of the transcription factor Oct-6 in Schwann cell myelina-
tion (Bermingham et al., 1996; Jaegle et al., 1996). Previ-
ously, it has been shown that expression of Oct-6 in
Schwann cells is regulated by the adenylyl cyclase-protein
kinase A (PKA) pathway (Monuki et al., 1989), and neural
crest-derived multipotent progenitors upregulate Oct-6 ex-
pression upon treatment with the adenylate cyclase activa-
tor forskolin (Hagedorn et al., 2000). Moreover, it has been
proposed that the PKA pathway synergizes with NRG1
signaling to stimulate Oct-6 expression (Mandemakers et
al., 2000). It is noteworthy, therefore, that in multipotent
progenitor cells, profound upregulation of Oct-6 expression
by locally presented NRG1 type III occurred in the absence
of exogenously added forskolin. Membrane-bound NRG1
may mimic the PKA pathway by activating similar target
proteins. In support of this hypothesis, crosstalk between
NRG1- and PKA-signal transduction pathways occurs and
likely activates CREB (cAMP response element-binding
protein) as a common downstream effector in cultures of
postnatal Schwann cells (Kim et al., 1997; Tabernero et al.,
1998).
Our findings that membrane-bound NRG1 type III as
opposed to soluble NRG1 isoforms is able to induce Oct-6
and S100 in multipotent neural crest-derived progenitors
raise the question of how the specific activities of NRG1
signaling are brought about. NRG1 signaling can be affected
by varying ErbB receptor combinations (reviewed in Buon-
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anno and Fischbach, 2001; Burden and Yarden, 1997). In the
developing PNS, this is an unlikely mechanism to control
differential NRG1 signaling since the receptor heterodimer
of ErbB2 and ErbB3 appears to be responsible for NRG1
signaling in all neural crest-derived glia at different stages
(Grinspan et al., 1996; Levi et al., 1995; Shah et al., 1994;
Vartanian et al., 1997). Moreover, similar to soluble NRG1
isoforms, membrane-bound NRG1 type III stimulates phos-
phorylation of ErbB2 and ErbB3 receptors (Ho et al., 1995;
Schroering and Carey, 1998). It is conceivable, however,
that a given ErbB receptor combination can discriminate
among signaling by different forms of NRG1. Different
NRG gene products can elicit differential usage of ErbB
phosphorylation sites or recruit different signaling proteins
to activated receptors, thereby stimulating distinct signal-
ing pathways (Pinkas-Kramarski et al., 1998; Sweeney et
al., 2000, 2001). Membrane association of NRG1 type III is
mediated by a hydrophobic domain in its N terminus,
FIG. 6. NRG1 type III-expressing cells, monitored by alkaline phosphatase expression, are associated with Oct-6-positive cells.
Dissociated embryonic rat DRG were infected and cultured for 4 days. Infection with NRG1-III virus (C, D) or with control virus (A, B) was
monitored by the presence of alkaline phosphatase (AP). Note that in the few cases in which control-infected cells were associated with
Schwann cells, usually only one cell expressed the Schwann cell marker Oct-6. In contrast, NRG1 type III-expressing cells were usually
associated with more than three Schwann cells. Phase-contrast (B, D). Magnification, 20.
FIG. 5. Oct-6- and S100-positive Schwann cells associate with cells expressing membrane-bound myc-tagged NRG1 type III. Cells
dissociated from E15 rat DRG were plated at high density onto fibronectin-coated plates and cultured over a period of 3–4 h. In order to
remove neurons from the plate, the cultures were rinsed with cold PBS. Subsequently, cells were replated onto pDL/fibronectin-coated
plates at high density and were infected with retrovirus expressing mycNRG1-III or with control retrovirus. Cultures were fixed after 4 days
and stained for the tagged fusion protein using anti-Myc antibody visualized by Cy3-conjugated secondary antibody (A, C, E, and G).
Anti-Oct-6 or anti-S100 antibody followed by a secondary antibody conjugated to FITC were used to reveal the presence of Schwann cells
in the cultures. Nonneuronal cells in close vicinity to mycNRG1-III expressing clusters (as monitored by anti-Myc immunoreactivity,
arrows) were found to express the Schwann cell markers S100 (C, D) or Oct-6 (G, H). Association of control-infected cells with Schwann
cells was found with a significantly lower frequency (see Fig. 7). Phase-contrast (B, D, F, and H). Magnification, 40.
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resulting in exposure of the C-terminal end of the ectodo-
main to the extracellular environment (Schroering and
Carey, 1998). Thus, the specific orientation of the NRG1
type III signaling domain might affect signal interpretation
by the signal-receiving cell. In addition, cofactors such as
PDZ-containing proteins or the transmembrane protein
CD44 that interact with ErbB receptors might modulate
NRG1 signaling (Garcia et al., 2000; Sherman et al., 2000).
Such mechanisms might also underlie the differential path-
way usage observed in postnatal Schwann cell motility,
survival, proliferation, and myelination (Li et al., 2001;
Maurel and Salzer, 2000; Meintanis et al., 2001).
Stage-Specific Responses of the Peripheral Glial
Lineage to NRG1 Signaling
The multiple biological responses of neural crest deriva-
tives to NRG signaling are not only triggered by the
differential activities of NRG forms. Rather, the compe-
tence of a neural crest cell to interpret a given NRG signal
apparently changes with time. NRG1 type II regulates
expression of the satellite glia marker Erm in multipotent
neural crest stem cells and DRG-derived progenitors, but
once such cells have populated peripheral nerves as
Schwann cell precursors, NRG1 type II is able to support
survival rather than Erm expression (Hagedorn et al., 2000;
this study). As mentioned above, signaling by membrane-
bound NRG1 type III appears to be dominant over NRG1
type II signaling, consistent with the idea that the exposure
of a cell to axon-mediated NRG1 type III alters its intrinsic
program and its capacity to interpret signaling by soluble
NRG1. Thereby, priming by NRG1 type III signaling might
be irreversible since a transition of an Erm-positive multi-
potent progenitor to a Schwann cell precursor but never of
a Schwann cell precursor to an Erm-expressing cell has been
observed (Hagedorn et al., 2000). Based on our data, we
conclude that continuous exposure to axon-derived,
membrane-bound NRG1 type III would then allow
Schwann cell precursors to survive and to differentiate into
Schwann cells.
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